Purchase Order 75N93020P01234
Award Date 8/28/20
Potential Completion Date 9/27/20
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
South Plainfield, NJ 07080, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Genewiz, LLC, a global contract research organization specializing in genomic services. The $37,046.85 contract is for gene synthesis, custom cloning, and variant synthesis. Genewiz has provided DNA and RNA sequencing, bioinformatics, and other genomic services to federal agencies such as the NIH, NCI, VA, and USGS...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to 10X Genomics, Inc. for Chromium Next GEM Single Cell 3' GEM library reagents on August 6, 2020, with a ceiling value of $12,399.00. Performance takes place in Bethesda, Maryland. The order is firm fixed price with no set-aside designation. Ultimate completion is September 5, 2020.</p>
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to 10X Genomics, Inc. valued at $56,632.25 on September 16, 2019, for a Chromium Controller & Next GEM Accessory Kit with 12-month warranty. Performance occurs at Bethesda, Maryland. The order carries a firm fixed price and an ultimate completion date of September 30, 2019.</p>
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to 10X Genomics, Inc. for $23,948.00 on August 6, 2020, for Chromium Next GEM Single Cell Reagents. Place of performance is Bethesda, Maryland. The order carries a firm fixed price structure with an ultimate completion date of September 11, 2020. The procurement was funded under the Coronavirus COVID-19 national interest action code. No small business set-aside was used.</p>
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to 10X Genomics, Inc. for $12,139.50 on April 7, 2020 for Chromium single-cell 3' GEM library and gel bead kit V3 (4 reactions) and Chromium I7 multiplex kit (96 reactions). Performance takes place in Pleasanton, California. The order is firm fixed price with an ultimate completion date of April 7, 2020 and carries a Coronavirus COVID-19 national interest action code. No set-aside was used.</p>
- The National Institute of Allergy and Infectious Diseases awarded a purchase order to 10X Genomics, Inc. on July 1, 2020, with a ceiling value of $22,817.50 for genomic analysis equipment and reagents. The order was a firm fixed-price acquisition without set-aside designation. Performance is located in Bethesda, Maryland, with an ultimate completion date of July 31, 2020. The purchase order procures specialized genomic research consumables and instruments, including single-cell analysis kits and...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Genscript USA Inc. for $14,756.36 on September 13, 2021, for sequencing services under the FY26 UDO Initiative. Performance is at Genscript's facility in Piscataway, New Jersey. The order carries a firm fixed price and was completed by December 31, 2021.</p>
- This federal contract award to Genewiz, LLC, a global contract research organization, was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The $5,300.00 firm fixed price purchase order is for other functions - whole genome sequencing of 8 samples. The award has no set-aside designation. Through this contract, Genewiz will provide specialized genomic services, including next-generation sequencing, to support research...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Genscript USA Inc. for $11,179.50 on November 18, 2019, for customized gene production, gene synthesis, and cloning services.</p> <p>Place of performance is Piscataway, New Jersey. The order carries a firm fixed price and ultimate completion date of December 6, 2019.</p>
- <p>The National Institutes of Health awarded a purchase order to Genewiz, LLC valued at $43,545.28 on May 11, 2021, under a Total Small Business set-aside. Performance is at Genewiz's facility in South Plainfield, New Jersey. The order is firm fixed price with an ultimate completion date of June 30, 2021. The specific requirements are not detailed in the source.</p>
The National Institute of Allergy and Infectious Diseases awarded a purchase order to Genewiz, LLC for $17,066.00 on August 28, 2020. The order covers 10X Genomics Chromium B-cell V(D)J library preparation and 10X library sequencing on Illumina HiSeq platforms, with data delivery via hard drive. Performance is at Genewiz's facility in South Plainfield, New Jersey, with an ultimate completion date of September 27, 2020. The contract carries firm fixed-price terms with no set-aside designation.
Generated 6/2/26, 9:45 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.1k | 8/27/20 |